Granulocyte colony-stimulating factor use during first urse chemotherapy for non-Hodgkin's lymphoma: National SEER-medicare study.

被引：0
|
作者：
Chrischilles, EA
Rubenstein, LM
Voelker, MD
Wright, KB
Link, BK
Brooks, JM
Delgado, DJ
机构：
[1] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1817
引用
收藏
页码：499A / 499A
页数：1
相关论文
共 50 条
  • [21] CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma - Reply
    Doorduijn, JK
    Sonneveld, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4799 - 4800
  • [22] Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen
    Guerci, A
    Lederlin, P
    Reyes, F
    Bordessoule, D
    Sebban, C
    Tilly, H
    Kerneis, Y
    Biron, P
    Gisselbrecht, C
    Herbrecht, R
    Coiffier, B
    ANNALS OF ONCOLOGY, 1996, 7 (09) : 966 - 969
  • [23] Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma
    Hashino, S.
    Morioka, M.
    Irie, T.
    Shiroshita, N.
    Kawamura, T.
    Suzuki, S.
    Iwasaki, H.
    Umehara, S.
    Kakinoki, Y.
    Kurosawa, M.
    Kahata, K.
    Izumiyama, K.
    Kobayashi, H.
    Onozawa, M.
    Takahata, M.
    Fujisawa, F.
    Kondo, T.
    Asaka, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (04) : 292 - 299
  • [24] Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma - A randomised pilot study
    Bergmann, L
    Karakas, T
    Knuth, A
    Lautenschlager, G
    Mitrou, PS
    Hoelzer, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2164 - 2168
  • [25] Clinical efficacy and cost benefit of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
    Hashino, Satoshi
    Morioka, Masanobu
    Irie, Tatsuro
    Shiroshita, Noriyuki
    Kawamura, Tsugumichi
    Suzuki, Sachiko
    Iwasaki, Hiroshi
    Umehara, Shintato
    Kakinoki, Yasutaka
    Kurosawa, Mitsutoshi
    Kahata, Kaoru
    Izumiyama, Koh
    Kobayashi, Hajime
    Onozawa, Masahiro
    Takahata, Mutsurni
    Fujisawa, Fumie
    Kondo, Takeshi
    Asaka, Masahiro
    BLOOD, 2006, 108 (11) : 249B - 250B
  • [26] Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: Results of a phase II study
    Gregory, SA
    Case, DC
    Bosserman, L
    Litwak, DL
    Berry, WR
    Kalman, LA
    Belt, RJ
    Saven, A
    CLINICAL LYMPHOMA, 2003, 4 (02): : 93 - 98
  • [27] Cost benefit analysis of prophylactic granulocyte colony stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma
    Dranitsaris, G
    Altmayer, C
    Quirt, I
    PHARMACOECONOMICS, 1997, 11 (06) : 566 - 577
  • [28] Patterns of Granulocyte Colony-Stimulating Factor Use Among Older Women with Breast Cancer: An Analysis of SEER-Medicare Linked Data, 2001-2009
    Lee, Wan-Ju
    Schwartz, Stephen M.
    Calip, Gregory S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 48 - 49
  • [29] Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients
    Toubai, Tomomi
    Tanaka, Junji
    Ota, Shuichi
    Fukuhara, Takashi
    Hashino, Satoshi
    Kondo, Takeshi
    Shono, Yusuke
    Morioka, Masanobu
    Kawamura, Tsugumichi
    Masauzi, Nobuo
    Kakinoki, Yasutaka
    Kobayashi, Hajime
    Kunieda, Yasuyuki
    Kasai, Masaharu
    Kurosawa, Mitsutoshi
    Asaka, Masahiro
    Imamura, Masahiro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (05) : 403 - 409
  • [30] History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis
    Chao, Chun
    Rodriguez, Roberto
    Page, John H.
    Yang, Su-Jau
    Huynh, Julie
    Chia, Victoria M.
    LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 72 - 79
12345